EGFR and cancer: When the EGFR is activated by ligands such as transforming growth factor (TGF) a, protein substrates, such as phospholipase C and phosphatidylinositol-3-kinase, are tyrosine phosphorylated, leading to increased cancer proliferation and survival [2,3].